Testing the safety of vaccines and biologics for infectious diseases
Official title: Task V11: General Safety Toxicity Testing
Funded at Battelle Centers/pub Hlth Res & Evaluatn · NIH-11257631 · Data updated 2026-11-12
This study is looking at new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism, and aims to make these vaccines safer and more effective for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Centers/pub Hlth Res & Evaluatn NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | September 17, 2021 |
| Project end | December 31, 2025 |
| Funding year | 2025 |
| Award (this year) | $629,831 |
| NIH project number | 272201800013I-P00007-759302100002-1 |
| Project ID | NIH-11257631 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those who may be affected by bioterrorism.
✕Less likely to help
Patients with established infectious diseases that are not targeted by the vaccines being developed may not receive benefit from this research.
What this research studies
This research focuses on evaluating and testing vaccines and other biologics aimed at preventing infectious diseases, including those that may arise from bioterrorism. It involves a comprehensive approach that includes administrative management, technical support, and quality oversight. The research also encompasses the development and validation of immune assays, immunogenicity and efficacy testing, and safety/toxicology studies. Patients may benefit from the development of new vaccines that are safer and more effective against emerging infectious threats.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective vaccines for infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines through similar evaluation and testing methodologies, indicating a promising approach.
Where this research is happening
-
Battelle Centers/pub Hlth Res & Evaluatn
Columbus, United States Active
Researchers
- Principal investigator: Rudge, Thomas — Battelle Centers/pub Hlth Res & Evaluatn
- Study coordinator: Rudge, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.